Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Takeda Closing In Again On Valeant Assets?

Executive Summary

Takeda and Valeant are rumored to have restarted talks over some form of potential deal, this time reportedly focusing on a possible offer by the Japanese firm for Valeant's gastrointestinal business unit Salix.

Advertisement

Related Content

Deal Watch: Bristol Leaves Neuropathic Pain Candidate To Lexicon
Valeant Is Weighing Offers For Assets As Stocks Plunges Again
Entyvio Takes Lead As Takeda Pursues Turnaround
Rumor Has It: Expect Valeant Divestitures?
Valeant: Another Fine Mess

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC097604

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel